Renin - angiotensin - aldosterone system inhibition and calcium channel inhibitors drug were the two most popular drug groups (65.8% and 37.1% respectively) .58.5% patients were treated following the multi-therapy regimen, in which17.6% patient had been used both of the Renin-angiotensin-aldosterone system inhibition and calcium channel inhibitors drugs.